Table 1.

The VTE‐BLEED score with original definition of variables (Klok et al, 2016)

Factor	Score
Active cancera	2
Male with uncontrolled arterial hypertensionb	1
Anaemiac	1·5
History of bleedingd	1·5
Age ≥60 years old	1·5
Renal dysfunctione	1·5
Classification of patients with the VTE‐BLEED score
Low bleeding risk	Total score <2
High bleeding risk	Total score ≥2

^aCancer diagnosed within 6 months before diagnosis of venous thromboembolism (VTE) (excluding basal‐cell or squamous‐cell carcinoma of the skin), recently recurrent or progressive cancer or any cancer that required anti‐cancer treatment within 6 months before the VTE was diagnosed.

^bMales with uncontrolled arterial hypertension were defined by values of systolic blood pressure ≥140 mmHg at baseline.

^cHaemoglobin <130 g/l in men or <120 g/l in women.

^dIncluding prior major or non‐major clinically relevant bleeding event, rectal bleeding, frequent nose bleeding, or haematuria.

^eAn estimated glomerular filtration rate (eGRF) <60 ml/min defined the presence of renal dysfunction: eGRF was calculated at baseline with the Cockcroft‐Gault formula, which include serum creatinine, age, and body weight.